24/7 Wall Street
28 Jul 2026, 13:47 UTC · 6w ago
Verdict
Headline leans bearish. We score MDT +0.30 across five claims.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.30moderately bullish
What the story claims
5 claims · scored −1 bearish … +1 bullish
Intuitive Surgical (ISRG) cut its full-year da Vinci procedure growth guidance to 13.5%-15.5%, down from 18% in 2025.
So whatGuidance cuts on core growth metrics typically trigger significant valuation multiple compression and immediate share price declines.
More negative than 98% of claims this week
ISRG management repurchased $379 million of stock in Q2 at an average price of $439, which is significantly above the current trading price of $356.83.
Continue reading
5 related stories
More positive than 60% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 91% of claims this week
The current share price of $356.83 represents a roughly 36% discount to the Wall Street consensus price target of $484.40.
More positive than 85% of claims this week
U.S. procedure growth is decelerating due to GLP-1 usage reducing bariatric cases, ACA premium dynamics, and softness in China tenders.
More negative than 80% of claims this week
ISRG's recurring revenue now accounts for approximately 85% of total revenue ($2.47 billion), providing a stable financial base.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 60% of ticker scores this week
Positive mentions of FDA clearance for the Hugo platform and 78% growth in Cardiac Ablation.
More positive than 60% of ticker scores this week
Analysts remain constructive due to the Mako platform and Inari vascular deal.
More negative than 69% of ticker scores this week
Despite beating Q2 estimates and strong recurring revenue, the company faced an 11% share drop and 37% YTD decline due to lowered full-year guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
4h ago
More positive than 76% of relationship scores this week
[mutual] Both companies compete in the surgical robotics market, specifically with the da Vinci and Hugo platforms.
More positive than 76% of relationship scores this week
[mutual] Both are identified as large-cap med device peers competing in the surgical robotics space.
+11.4%
Price agrees with the score
$93.80 vs $84.22 close before publication (Jul 27) · not market-adjusted
MDT chart →
